By Kamal Choudhury (Reuters) -Shares of AnaptysBio fell more than 5% on Friday after the U.S. drug developer and GSK's oncology unit, Tesaro, filed lawsuits against each other, with both claiming a ...

Dow Jones Top Company Headlines at 7 AM ET: Paramount, Comcast and Netflix Submit Bids for Warner Bros. Discovery | GSK, ... Paramount, Comcast and Netflix Submit Bids for Warner Bros. Discovery Of ...

The global glucosamine supplement market is on track for consistent expansion, projected to increase from USD 641.0 million ...

WHO emphasizes integrating surveillance into national STI programs. Zoliflodacin, a novel antimicrobial agent, shows promise in treating gonorrhea, demonstrating non-inferiority to ...

GSK is investing £45m with the Fleming Initiative to launch six research programmes using cutting-edge AI to tackle ...

Spherix Global Insights has released the first wave of Launch Dynamix(TM): Gazyva in Lupus Nephritis, providing the earliest independent read on the commercial introduction of Gazyva(R) (obinutuzumab, ...

(Alliance News) - GSK PLC and Fleming Initiative on Wednesday unveiled six major research programmes aimed at tackling antimicrobial resistance, committing GBP45 million to projects that will harness ...

GSK has paid $50 million upfront to partner with LTZ Therapeutics on myeloid cell engagers, expanding its cancer pipeline to cover a modality that has attracted Eli Lilly, Novartis, Pfizer and Sanofi.

Discover Forbes' 2025 CIO Next list, featuring top Chief Information Officers and tech leaders driving transformation and ...

GSK funding allocated to six new research programmes which will combine expertise and using cutting edge AI technology to ...

Day One Biopharmaceuticals, Inc. to Acquire Mersana Therapeutics, Inc.Agreement provides for upfront consideration of $25.00 per share in cash, ...

A strong performer already, GSK stock is trading up 44% in 2025, yet its stock remains a good bargain. GSK trades for a ...